InMed Pharmaceuticals (INM) Invested Capital (2021 - 2025)
Historic Invested Capital for InMed Pharmaceuticals (INM) over the last 5 years, with Q4 2025 value amounting to $9.6 million.
- InMed Pharmaceuticals' Invested Capital rose 5508.75% to $9.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.6 million, marking a year-over-year increase of 5508.75%. This contributed to the annual value of $13.4 million for FY2025, which is 4593.02% up from last year.
- Per InMed Pharmaceuticals' latest filing, its Invested Capital stood at $9.6 million for Q4 2025, which was up 5508.75% from $11.6 million recorded in Q3 2025.
- In the past 5 years, InMed Pharmaceuticals' Invested Capital ranged from a high of $15.2 million in Q3 2021 and a low of -$9.6 million during Q3 2023
- Its 5-year average for Invested Capital is $9.9 million, with a median of $11.1 million in 2022.
- As far as peak fluctuations go, InMed Pharmaceuticals' Invested Capital plummeted by 18701.07% in 2023, and later skyrocketed by 18765.26% in 2024.
- Over the past 5 years, InMed Pharmaceuticals' Invested Capital (Quarter) stood at $14.2 million in 2021, then rose by 0.77% to $14.3 million in 2022, then dropped by 10.9% to $12.8 million in 2023, then tumbled by 51.6% to $6.2 million in 2024, then surged by 55.09% to $9.6 million in 2025.
- Its Invested Capital stands at $9.6 million for Q4 2025, versus $11.6 million for Q3 2025 and $13.4 million for Q2 2025.